These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 15977626)

  • 1. [BOT with insulin glargine versus BOT with insulin detemir: comparison of treatment costs in type 2 diabetes based on the results of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study from the German Statutory Health Insurance perspective].
    Schädlich PK; Koltermann KC; Dippel FW; Hagenmeyer EG; Häussler B
    MMW Fortschr Med; 2010 Oct; 152 Suppl 3():89-95. PubMed ID: 21595152
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for patients. Inhaled insulin with or instead of oral medications for type 2 diabetes.
    Ann Intern Med; 2005 Oct; 143(8):I28. PubMed ID: 16230717
    [No Abstract]   [Full Text] [Related]  

  • 3. [New, expensive antidiabetics for the treatment of type-2 diabetes--contra].
    Nawroth P
    Dtsch Med Wochenschr; 2010 May; 135(18):923. PubMed ID: 20425679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin therapy in type 2 diabetes].
    Hummel M
    MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
    [No Abstract]   [Full Text] [Related]  

  • 5. [When injectable diabetes therapy becomes necessary. Insulin or GLP-1 analogs?].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Jan; 153(1-2):14. PubMed ID: 24761480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost saving program instead of optimizing therapy: disease mismanagement in diabetes mellitus? (interview by Dr. med. Jochen Aumiller)].
    Rett K
    MMW Fortschr Med; 2005 Jun; 147(22):15. PubMed ID: 15977626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetes in old age--risk by over- and undertreatment].
    Zeyfang A; Bahrmann A
    MMW Fortschr Med; 2013 Jul; 155(13):56-8. PubMed ID: 23964510
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-acting insulins in the treatment of type 2 diabetes: a hard choice].
    Liebl A
    MMW Fortschr Med; 2015 Apr; 157(7):65-8. PubMed ID: 26012462
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral treatment of type 2 diabetes mellitus].
    Palitzsch KD
    Dtsch Med Wochenschr; 2012 Sep; 137(38):1859-68, quiz 1869-72. PubMed ID: 22971973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin glargine. The most studied basal insulin].
    Walter M
    MMW Fortschr Med; 2013 Nov; 155(19):70-1. PubMed ID: 24475676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of insulin analogues in the treatment of people with type 2 diabetes].
    Gallwitz B; Westrup D; Schmeisl GW
    Dtsch Med Wochenschr; 2014 Oct; 139(43):2199-203. PubMed ID: 25317651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should the last be first? Questions and dilemmas regarding early short-term insulin treatment in Type 2 Diabetes Mellitus.
    Koufakis T; Karras SN; Zebekakis P; Ajjan R; Kotsa K
    Expert Opin Biol Ther; 2018 Nov; 18(11):1113-1121. PubMed ID: 30244600
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.